All the news Showing 10 of 52 articles from: Transmission and preventionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Risk of reinfection is a concern after successful hepatitis C treatment Liz Highleyman / 28 September 2016 People on opiate agonist substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier) – achieving cure rates similar to those of the population as a whole – but some people are reinfected ... HCV treatment is effective and may work as prevention for people who inject drugs Liz Highleyman / 19 September 2016 Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating enough people in this population could ... Hepatitis C vaccine development shows progress but scientific barriers remain Liz Highleyman / 12 September 2016 An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and incomplete natural immunity, according to presentations ... Vaccination could have important role in control of UK HCV epidemic among people who inject drugs Michael Carter / 29 June 2016 A vaccine, even with low efficacy, could lead to meaningful reductions in the incidence and prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID), a modelling study published in PLOS ... High incidence of HCV reinfection among HIV-positive MSM in Western Europe Michael Carter / 19 April 2016 There is a very high incidence of hepatitis C virus (HCV) reinfection among HIV-positive men who have sex with men (MSM) in western Europe, according to research presented to the International Liver Congress ... A third of MSM with HIV/HCV co-infection have HCV in their semen Michael Carter / 11 April 2016 Hepatitis C virus (HCV) is present in the semen of a third of co-infected HIV-positive men who have sex with men (MSM), investigators from the United States report in Open Forum Infectious ... HCV epidemic in North America peaked between 1940 and 1965 with medical procedures likely source of most infections Michael Carter / 04 April 2016 The spread of hepatitis C virus (HCV) in North America peaked between 1940 and 1965, according to research published in Lancet Infectious Diseases. The investigators attribute the rapid spread of the infection to hospital ... Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs Liz Highleyman / 30 October 2015 An emergency syringe exchange program implemented after an outbreak of HIV earlier this year in the state of Indiana led to a decrease in risk behaviours including needle sharing during its first five ... Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs Roger Pebody / 28 October 2015 While epidemiologists and public health experts are excited by the potential of new hepatitis C drugs to limit onward transmission of the virus among people who inject drugs, the strategies ignore profound ... Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs Roger Pebody / 22 October 2015 The numbers of people injecting steroids and other image-enhancing drugs has increased significantly in the last decade and harm reduction services need to develop new skills if they are to help ... ← Prev1...23456Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive